| Thursday, September 24, 2009 | ||
| 11:30:00 | Drug-Induced Nephrotoxicity – Multiplex Detection of Key Kidney Damage Biomarkers in Rat Urine | |
| 11:30:00 | Technology Showcase: Protein Biomarkers | |
| 11:45:00 | The Speed and Flexibility of Building Protein Biomarker Assays with the Peptide MRM Method Nextgen logo | Michael Pisano |
| 12:15:00 | Sponsored Presentation To Be Announced | |
| 12:30:00 | Lunch on your own | |
| 14:00:00 | Plenary Keynotes | |
| 14:30:00 | Enabling Personalized Medicine through Application of Biomarkers in Clinical Development | Nicholas C. Dracopoli |
| 14:30:00 | Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks | J. Carl Barrett |
| 15:00:00 | Networking Refreshment Break with Poster and Exhibit Viewing | |
| 15:00:00 | Protein Biomarkers for Cancer Targeted Therapy | |
| 16:00:00 | Towards a More Efficient Protein Biomarker Development Process | Henry Rodriguez |
| 16:30:00 | Use of Activated Protein Pathway Biomarkers at the Bedside: Realizing the Promise of Personalized Therapy | Emanuel F. Petricoin |
| 17:00:00 | Towards Renal Cell Carcinoma Biomarker Discovery using Personalized Oncoproteomics | Josip Blonder |
| 17:30:00 | MRM and iMALDI for Protein Biomarker Discovery and Validation | Christoph H. Borchers |
| 18:00:00 | Close of Day | |
| Friday, September 25, 2009 | ||
| 07:30:00 | Breakfast Presentations (Opportunities Available) | |
| 08:15:00 | Protein Biomarkers for Cancer | |
| 08:25:00 | Chairperson’s Opening Remarks | |
| 08:30:00 | Accelerating Biomarker Discovery through an Integrated Organ Specific Approach | O. John Semmes |
| 09:00:00 | Nanoscale Proteomic Analysis of Clinical Oncology Specimens for Drug Discovery | Dean W Felsher |
| 09:30:00 | An Integrated Approach to Serum Marker Identification of Gastric Cancer | Juan Cui |
| 10:00:00 | Networking Coffee Break | |
| 10:00:00 | Protein Biomarker Discovery | |
| 10:30:00 | Proteomics - From Basic Research to the Clinic | Ronald C. Hendrickson |
| 11:00:00 | Rationale Ovarian Cancer Biomarker Discovery: The Importance of Longitudinal Experimental Designs | David C. Muddiman |
| 11:30:00 | High-Throughput Cell-Based Studies and Protein Microarrays for Biomarker and Target Discovery | Fernanda Festa |
| 12:00:00 | Close of Congress | |
| 12:00:00 | New Presentation | |
| 12:05:00 | End of the conference | |
How We Rank